Thal G D, Szabo M D, Lopez-Bresnahan M, Crosby G
Harvard Medical School, Boston, Massachusetts, USA.
Anesthesiology. 1996 Jul;85(1):21-5; discussion 29A-30A. doi: 10.1097/00000542-199607000-00004.
Transient focal neurologic deficits have been observed in patients emerging from brain tumor or carotid surgery, and a pharmacologic effect of anesthetic agents has been proposed as the cause of such neurologic dysfunction. Therefore, the effect of sedation with midazolam or fentanyl on motor neurologic function was studied prospectively and preoperatively in patients with carotid disease or mass lesions of the brain.
Fifty-four unpremedicated adult patients with carotid disease or a brain tumor were given small intravenous doses of either 2.8 +/- 1.3 mg midazolam or 170 +/- 60 micrograms fentanyl in the preoperative period. A thorough motor examination was performed at baseline and after sedation by an individual who was unaware of the details of the patient's disease or symptoms. A mental status examination also was performed to control for the effects of inattentiveness or lack of cooperation during the neurologic examination.
Patients were sedated mildly but were fully cooperative. Focal motor deterioration occurred after sedation in 30% of patients, and the incidence was similar in patients in the fentanyl and midazolam groups. Among patients with a focal motor abnormality on baseline examination or a resolved prior motor deficit, 73% had exacerbation or unmasking of these signs by sedation, whereas no patient without a prior history of motor dysfunction had a sedative-induced change. Sedative-induced changes in neurologic function ranged from unilateral mild weakness to complete plegia, but appeared to be transient in nature.
Sedation with midazolam or fentanyl can transiently exacerbate or unmask focal motor deficits in patients with prior motor dysfunction.
在脑肿瘤或颈动脉手术后苏醒的患者中观察到短暂性局灶性神经功能缺损,有人提出麻醉药物的药理作用是这种神经功能障碍的原因。因此,前瞻性地在术前研究了咪达唑仑或芬太尼镇静对患有颈动脉疾病或脑肿块病变患者运动神经功能的影响。
54例未使用术前药的患有颈动脉疾病或脑肿瘤的成年患者在术前接受小剂量静脉注射2.8±1.3mg咪达唑仑或170±60μg芬太尼。由一名对患者疾病或症状细节不知情的人员在基线时和镇静后进行全面的运动检查。还进行了精神状态检查,以控制神经检查期间注意力不集中或不合作的影响。
患者被轻度镇静但完全合作。30%的患者在镇静后出现局灶性运动功能恶化,芬太尼组和咪达唑仑组患者的发生率相似。在基线检查时有局灶性运动异常或既往运动功能缺损已缓解的患者中,73%的患者因镇静使这些体征加重或暴露,而既往无运动功能障碍病史的患者无镇静诱导的变化。镇静诱导的神经功能变化范围从单侧轻度无力到完全瘫痪,但似乎本质上是短暂的。
咪达唑仑或芬太尼镇静可使既往有运动功能障碍的患者短暂性加重或暴露局灶性运动缺损。